Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | BuyD (derivative) | $75M | First in 12mo | SEC |